Elliott Wave + Cup Structure Alignment on a Fundamentally Strong Pharma Stock!

The monthly chart is displaying a strong Cup formation breakout around the ₹1,000 zone, where price has successfully reclaimed a major resistance area after a prolonged consolidation phase. The rounded base structure suggests steady accumulation and indicates a shift from supply dominance toward stronger buying participation. From an Elliott Wave perspective, the structure appears particularly interesting. The current setup hints that the stock may be entering a fresh 5-wave impulsive cycle, with the recent breakout potentially marking the beginning of Wave-(1). If momentum sustains, the progression toward Wave-(3) and Wave-(5) can become the major trend-driving phases, which are often associated with strong expansion moves. The momentum profile also supports the bullish structure through a likely bullish MACD divergence, where underlying momentum improved while price spent several months consolidating. Such divergences frequently emerge before visible trend acceleration and often provide early confirmation signals. Price is also reclaiming an important AVWAP zone, which can now act as institutional support. Sustaining above this anchored level generally reflects stronger conviction from larger market participants and improves the probability of trend continuation. The fundamental picture further strengthens the setup: ✔ Strong ROCE with efficient capital allocation ✔ Consistent earnings and profit growth visibility ✔ Robust pharmaceutical business with diversified product presence When Elliott Wave structure, MACD confirmation, AVWAP strength, breakout patterns, and quality fundamentals align together, it often creates high-probability setups. The key area to monitor now is sustained strength above the breakout zone, which can confirm the beginning of the next expansion phase.